These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Predictors of metabolic risk in childhood obesity. Morandi A; Maffeis C Horm Res Paediatr; 2014; 82(1):3-11. PubMed ID: 24923289 [TBL] [Abstract][Full Text] [Related]
43. Diabetes and cardiovascular disease. Resnick HE; Howard BV Annu Rev Med; 2002; 53():245-67. PubMed ID: 11818473 [TBL] [Abstract][Full Text] [Related]
44. [Metabolic syndrome with a predisposition to coronary diseases and type 2 diabetes]. Couffinhal T; Boulon C Nephrol Ther; 2006 Jan; 2 Suppl 1():S39-48. PubMed ID: 17378139 [TBL] [Abstract][Full Text] [Related]
45. The metabolic syndrome: validity and utility of clinical definitions for cardiovascular disease and diabetes risk prediction. Cameron A Maturitas; 2010 Feb; 65(2):117-21. PubMed ID: 20031349 [TBL] [Abstract][Full Text] [Related]
46. Pathophysiology of the metabolic syndrome: implications for the cardiometabolic risks associated with type 2 diabetes. Leroith D Am J Med Sci; 2012 Jan; 343(1):13-6. PubMed ID: 22205060 [TBL] [Abstract][Full Text] [Related]
47. Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications. Abate N J Diabetes Complications; 2000; 14(3):154-74. PubMed ID: 10989324 [TBL] [Abstract][Full Text] [Related]
48. Mechanisms of the components of the metabolic syndrome that predispose to diabetes and atherosclerotic CVD. Eckel RH Proc Nutr Soc; 2007 Feb; 66(1):82-95. PubMed ID: 17343775 [TBL] [Abstract][Full Text] [Related]
49. [Metabolic syndrome: limited significance for clinical practice]. Dekker JM; Diamant M; Nijpels G; Heine RJ Ned Tijdschr Geneeskd; 2005 Apr; 149(16):855-8. PubMed ID: 15868988 [TBL] [Abstract][Full Text] [Related]
50. The metabolic syndrome and cardiovascular disease - an ongoing tsunami. Hanefeld M; Pistrosch F Pediatr Endocrinol Diabetes Metab; 2013; 20(1):5-11. PubMed ID: 25612864 [TBL] [Abstract][Full Text] [Related]
51. [Obesity and the metabolic syndrome: a new epidemic]. Bordier L; Cremades S; Dupuy O; Mayaudon H; Bauduceau B Bull Acad Natl Med; 2009 Jun; 193(6):1289-300; discussion 1301. PubMed ID: 20120160 [TBL] [Abstract][Full Text] [Related]
52. [From "deadly quartet" to "metabolic syndrome". An analysis of its clinical relevance]. Vancheri F; Burgio A; Dovico R Recenti Prog Med; 2007 Mar; 98(3):192-200. PubMed ID: 17484168 [TBL] [Abstract][Full Text] [Related]
53. Potatoes and risk of obesity, type 2 diabetes, and cardiovascular disease in apparently healthy adults: a systematic review of clinical intervention and observational studies. Borch D; Juul-Hindsgaul N; Veller M; Astrup A; Jaskolowski J; Raben A Am J Clin Nutr; 2016 Aug; 104(2):489-98. PubMed ID: 27413134 [TBL] [Abstract][Full Text] [Related]
54. [Cardiovascular disease and metabolic syndrome]. Maranghi M; Coletta P; Durante C; Pergolini D; Filetti S Recenti Prog Med; 2006 Dec; 97(12):719-26. PubMed ID: 17252730 [TBL] [Abstract][Full Text] [Related]
55. The metabolic syndrome and endothelial dysfunction: common highway to type 2 diabetes and CVD. Diamant M; Tushuizen ME Curr Diab Rep; 2006 Aug; 6(4):279-86. PubMed ID: 16879779 [TBL] [Abstract][Full Text] [Related]
56. Metabolic Syndrome, Type 2 Diabetes, and Cancer: Epidemiology and Potential Mechanisms. Ben-Shmuel S; Rostoker R; Scheinman EJ; LeRoith D Handb Exp Pharmacol; 2016; 233():355-72. PubMed ID: 25903410 [TBL] [Abstract][Full Text] [Related]
57. [Is the metabolic syndrome still a useful entity?]. Charbonnel B Rev Prat; 2010 Apr; 60(4):478-84. PubMed ID: 20465120 [TBL] [Abstract][Full Text] [Related]
59. The relevance of the metabolic syndrome. Taslim S; Tai ES Ann Acad Med Singap; 2009 Jan; 38(1):29-5. PubMed ID: 19221668 [TBL] [Abstract][Full Text] [Related]